37,757 Shares in Agilent Technologies, Inc. (NYSE:A) Purchased by Edgestream Partners L.P.

Edgestream Partners L.P. bought a new position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 37,757 shares of the medical research company's stock, valued at approximately $4,417,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Brighton Jones LLC grew its holdings in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after purchasing an additional 270 shares during the period. Independent Advisor Alliance grew its holdings in Agilent Technologies by 64.6% in the fourth quarter. Independent Advisor Alliance now owns 2,397 shares of the medical research company's stock valued at $322,000 after purchasing an additional 941 shares during the period. HighTower Advisors LLC grew its holdings in Agilent Technologies by 6.6% in the fourth quarter. HighTower Advisors LLC now owns 71,413 shares of the medical research company's stock valued at $9,594,000 after purchasing an additional 4,432 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Agilent Technologies by 17.9% in the fourth quarter. EverSource Wealth Advisors LLC now owns 957 shares of the medical research company's stock valued at $129,000 after purchasing an additional 145 shares during the period. Finally, Commonwealth Equity Services LLC grew its holdings in Agilent Technologies by 9.8% in the fourth quarter. Commonwealth Equity Services LLC now owns 43,862 shares of the medical research company's stock valued at $5,892,000 after purchasing an additional 3,915 shares during the period.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the sale, the chief executive officer owned 37,448 shares in the company, valued at $4,397,893.12. The trade was a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $113.21 on Wednesday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The company has a market cap of $32.16 billion, a price-to-earnings ratio of 27.95, a PEG ratio of 3.64 and a beta of 1.23. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.60 and a current ratio of 2.09. The business's 50 day moving average price is $115.63 and its 200 day moving average price is $122.49.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.63 billion. During the same quarter last year, the business posted $1.22 earnings per share. The firm's revenue was up 6.0% compared to the same quarter last year. On average, research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.88%. Agilent Technologies's payout ratio is 24.44%.

Analyst Upgrades and Downgrades

A has been the topic of several research analyst reports. Barclays raised their price objective on Agilent Technologies from $115.00 to $125.00 and gave the company an "equal weight" rating in a report on Tuesday, June 24th. TD Cowen raised their target price on Agilent Technologies to $150.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. UBS Group decreased their target price on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research report on Thursday, May 29th. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. Finally, Wells Fargo & Company decreased their target price on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $139.77.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.